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Abstract
Objective: To determine morbidity and mortality rates by risk category in accordance with the American College 
of Chest Physicians guidelines, to determine what role pulmonary function tests play in this categorization 
process, and to identify risk factors for perioperative complications (PCs). Methods: This was a historical cohort 
study based on preoperative and postoperative data collected for cases of lung cancer diagnosed or suspected 
between 2001 and 2010. Results: Of the 239 patients evaluated, only 13 (5.4%) were classified as being at 
high risk of PCs. Predicted postoperative FEV1 (FEV1ppo) was sufficient to define the risk level in 156 patients 
(65.3%); however, cardiopulmonary exercise testing (CPET) was necessary for identifying those at high risk. Lung 
resection was performed in 145 patients. Overall morbidity and mortality rates were similar to those reported 
in other studies. However, morbidity and mortality rates for patients at an acceptable risk of PCs were 31.6% 
and 4.3%, respectively, whereas those for patients at high risk were 83.3% and 33.3%. Advanced age, COPD, 
lobe resection, and lower FEV1ppo were correlated with PCs. Conclusions: Although spirometry was sufficient 
for risk assessment in the majority of the population studied, CPET played a key role in the identification of 
high-risk patients, among whom the mortality rate was seven times higher than was that observed for those 
at an acceptable risk of PCs. The risk factors related to PCs coincided with those reported in previous studies.
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Resumo
Objetivo: Determinar as taxas de morbidade e mortalidade por categoria de risco conforme as diretrizes do 
American College of Chest Physicians, verificar como exames funcionais participaram dessa categorização e 
identificar fatores de risco para complicações perioperatórias (CPOs). Métodos: Estudo de coorte histórica a 
partir de avaliações pré e pós-operatórias de casos diagnosticados ou suspeitos de câncer de pulmão avaliados 
entre 2001 e 2010. Resultados: Dos 239 pacientes avaliados, apenas 13 (5,4%) foram considerados como de alto 
risco para CPOs. O cálculo do VEF1 previsto para o pós-operatório (VEF1ppo) foi suficiente para a estratificação 
do risco em 156 pacientes (65,3%); entretanto, o teste de exercício cardiopulmonar (TECP) foi necessário para 
a identificação de alto risco. Foram operados 145 pacientes, e as taxas globais de morbidade e mortalidade 
encontradas foram semelhantes às de outros estudos. Entretanto, as taxas de morbidade e mortalidade para 
aqueles com risco aceitável foram de 31,6% e 4,3%, respectivamente, enquanto as taxas para aqueles com 
alto risco foram de 83,3% e 33,3%. Idade mais avançada, presença da DPOC, ressecção de um ou mais lobos 
e VEF1ppo mais baixo estiveram relacionados à ocorrência de CPOs. Conclusões: Embora a espirometria tenha 
sido suficiente para a determinação de risco na maioria da população estudada, o TECP teve papel fundamental 
na identificação de pacientes com risco alto, que apresentaram uma taxa de mortalidade sete vezes maior que 
os de risco aceitável. Os fatores de risco relacionados a CPOs coincidiram aos relatados em outros estudos. 
Descritores: Algoritmos; Neoplasias pulmonares; Complicações pós-operatórias.
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suspicion of concomitant interstitial disease, when 
there was a history of neoadjuvant chemotherapy, 
or when the intensity of dyspnea reported was 
disproportionate to the measured FEV1 as a 
percentage of the predicted value. Referral for 
CPET occurred when either predicted postoperative 
FEV1 (FEV1ppo) or predicted postoperative DLCO 
(DLCOppo) was less than 40%, or when the 
patient was unable to perform acceptable DLCO 
measurement maneuvers. Patients who were 
unable to perform CPET properly were classified 
as being at high risk.
In the post-operative period, patients received 
physical therapy and pain management from 
specialized teams until they were discharged 
from the hospital.
The outcome measures analyzed, i.e., morbidity 
and mortality rates, included events occurring 
by postoperative day 30. Described in a previous 
study,(7) the definitions of PCs were as follows: 
respiratory or cardiovascular events causing 
intraoperative instability; lower respiratory tract 
infection; atelectasis; acute respiratory failure; 
acute myocardial infarction; atrial arrhythmia 
requiring treatment; congestive heart failure; 
bronchopleural fistula; pleural empyema; air leak 
lasting 7 days or longer; hemothorax; reoperation; 
and need for oxygen therapy on postoperative 
day 30.
In the statistical analysis, morbidity and 
mortality rates are expressed as simple percentages. 
In order to determine whether the functional 
values were associated with PCs, we had to 
recalculate them, adjusting them to the extent 
of the resection performed rather than maintaining 
them in accordance with the planned resection. 
The resulting values were called true FEV1ppo 
and true DLCOppo. In order to identify which 
variables were correlated with PCs, we used 
Pearson’s chi-square test and the Student’s t-test.
Results
Of the 262 who were eligible for the study, 
239 (91.2%) underwent all steps of the ACCP 
algorithm, whereas 23 (8.8%) did not. The clinical 
and functional characteristics of those 239 patients 
are shown in Table 1.
In 156 patients (65.3%), FEV1 was ≥ 80% or 
FEV1ppo was ≥ 40%, and no other tests were 
needed to complete the evaluation. However, 8 
patients (3.3%) had a FEV1ppo ≤ 40% and were 
therefore referred for CPET.
Introduction
Functional evaluation of candidates for lung 
resection for the treatment of lung cancer can 
be guided by various algorithms, of which the 
most known are those proposed by the consensus 
guidelines of the American College of Chest 
Physicians (ACCP)(1) and the European Respiratory 
Society/European Society of Thoracic Surgeons.(2) 
Although the use of these tools would potentially 
reduce morbidity and mortality rates, their 
application is compromised, because tests that 
are not readily available for most physicians, 
such as DLCO measurement and, especially, 
cardiopulmonary exercise testing (CPET), are 
required.(3-5)
The main difference between the two 
algorithms lies in the referral for those tests, 
although there have been no studies comparing 
the superiority of one over the other. However, 
it has been reported that, when no algorithm 
was used, evaluation errors were common, with 
the highest frequency of these errors occurring 
among less experienced physicians.(5,6)
Having been published before the European 
algorithm, the ACCP algorithm has been used in 
the preoperative evaluation center of the Federal 
University of São Paulo in the last 10 years. 
The objective of this study was to share our 
experience by providing morbidity and mortality 
rates by risk category, as well as to report the 
role played by DLCO measurement and CPET in 
this categorization process and the risk factors 
associated with perioperative complications (PCs).
Methods
This was a historical cohort study of a database 
of preoperative evaluations of patients diagnosed 
with or clinically suspected of having lung cancer, 
performed at the Hospital São Paulo, located in 
the city of São Paulo, Brazil, between January 
1, 2001 and December 31, 2010. The project 
was approved by the Research Ethics Committee 
of the Federal University of São Paulo (Protocol 
no. 1487/11).
The evaluation algorithm proposed by the ACCP 
consensus guidelines was applied after patients 
had achieved their best clinical and functional 
status. Figure 1 illustrates the algorithm and the 
surgical risk categorization. All patients underwent 
spirometry, and referral for DLCO measurement 
occurred when there was clinical and radiological 
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were unable to perform acceptable maneuvers. 
Of the 76 remaining patients, 60 (73.2%) had 
FEV1ppo and DLCOppo values > 40% predicted 
Of the 239 patients, 82 (34.3%) were referred 
for DLCO measurement. However, 6 of those 82 
did not undergo DLCO measurement because they 
Table 1 - Demographic, clinical, and pulmonary function data of the 239 candidates evaluated.a
Variable Result
Age, yearsb 59.0 ± 12.0
Neoadjuvant chemotherapy 17 (7.1)
COPD 78 (32.6)
Other comorbidities 104 (43.5)
Systemic arterial hypertension 93 (89.4)
Diabetes mellitus 35 (33.6)
Coronary artery disease 7 (6.7)
Chronic renal disease 5 (4.8)
Heart failure 2 (1.9)
FEV1, % of predicted
b 86.2 ± 20.8
DLCO, % of predictedb 67.6 ± 18.3
aValues expressed as n (%), except where otherwise indicated. bValues expressed as mean ± SD.
Spirometry / DLCO measurement
Any < 80%
Calculation of regional pulmonary function
Perform CPET
Acceptable risk High risk High risk
VO2peak > 15
mL . Kg-1 . min-1
VO2peak between 15-10
mL . Kg-1 . min-1
VO2peak < 10







FEV1ppo < 30% ou
% FEV1ppo x
% DLCOppo < 1650
Figure 1 - Algorithm proposed by the American College of Chest Physicians. ppo: predicted postoperative; 
CPET: cardiopulmonary exercise testing; and VO2peak: peak oxygen uptake.
24 Stanzani F, Paisani DM, Oliveira A, Souza RC, Perfeito JAJ, Faresin SM
J Bras Pneumol. 2014;40(1):21-29
and a diagnosis of benign disease by a method 
other than the initially planned surgery.
A diagnosis of malignancy was confirmed in 
105 operated patients (72.4%), adenocarcinoma 
being the most common histological type (in 
40.0%). In 27.6% of the patients, the histological 
diagnoses were benign, the majority (59.5%) 
corresponding to nonspecific benign lesions 
and tuberculomas.
Morbidity and mortality rates for patients 
classified preoperatively as being at an acceptable 
risk of PCs were, respectively, 31.6% and 4.3% 
(6 deaths), whereas those for patients at high 
risk were 83.3% and 33.3% (2 deaths). In the 
reclassification of patients by extent of the 
procedure, 4 of the 139 patients classified as 
being at an acceptable risk would be referred for 
CPET so that the evaluation could be completed. 
Of the 6 patients classified as being at high 
risk, 4 remained so and 2 were reclassified as 
being at an acceptable risk. After recalculation, 
morbidity and mortality rates were, respectively, 
31.4% and 3.6% for those at an acceptable risk 
and 100% and 50.0% for those at high risk. 
Table 2 shows the morbidity and mortality rates 
of patients classified as being at an acceptable 
risk, by tests performed.
In a comparison of patients who had PCs 
with those who did not, statistically significant 
differences were found in the following variables: 
age; lobe resection; true FEV1ppo as a percentage 
of the predicted value; and COPD (Table 3).
Discussion
The use of the ACCP algorithm showed that, 
among patients classified as being at high risk of 
PCs, the mortality rate was seven to thirteen times 
higher than was that observed for those classified 
as being at an acceptable risk. This difference 
occurred in the context of overall morbidity 
and mortality rates being consistent with those 
reported by other health care facilities.(8-10) This 
finding revealed that the algorithm provided a 
good prediction of patient risk, identifying those 
who require more attention and investment both 
before and after the procedure.
Whereas only calculation of FEV1ppo was 
needed in the evaluation of the majority of 
the study population, who had a favorable 
postoperative course, a DLCOppo value < 
40% determined the need for CPET five times 
more often than did a FEV1ppo value < 40%. 
and were classified, at the end of the preoperative 
evaluation, as being at an acceptable risk of PCs. 
Of the 14 patients who had a DLCOppo < 40%, 
13 had a FEV1ppo > 40%. A total of 23 patients 
(9.6%) were referred for CPET, and 13 (56.5%) of 
them were classified as being at high risk for the 
following reasons: having a peak oxygen uptake 
≤ 15 mL • kg−1 • min−1 (6 patients); performing 
submaximal exercise or being unable to pedal (4 
patients); not having undergone CPET because 
of an unknown reason (2 patients); and not 
having undergone CPET because the machine 
was broken (1 patient). Figure 2 illustrates the 
application of the algorithm, which classified 
13 patients (5.4%) as being at high risk of PCs 
and 226 (94.6%) as being at an acceptable risk.
One hundred and fifty-one patients (63.2%) 
were operated on. Six of them did not undergo 
resection of lung parenchyma and were therefore 
disregarded in the remaining analyses. Of the 
remainder, 139 and 6 were classified as being 
at an acceptable and high risk, respectively. 
In 49.6% of those procedures, the amount of 
parenchyma resected was smaller than planned; in 
most cases, because malignant disease was ruled 
out by intraoperative frozen-section analysis. In 
9.3%, a greater amount of tissue was resected 
because of the progression of cancer. The 
following procedures were performed: lobectomy 
(in 38.6% of the cases); resection of less than 
one segment (in 29.0%); segmentectomy (in 
17.9%); pneumonectomy (in 8.3%); bilobectomy 
(in 4.8%); and bisegmentectomy (in 1.4%).
Of the 145 patients operated on, 49 had PCs, 
the morbidity rate being 33.8% and the overall 
mortality rate being 5.5% (8 deaths). There were 
101 PCs, the most common being prolonged 
air leak (in 19.8%), lower airway respiratory 
infection (in 19.8%), and acute respiratory failure 
(in 17.8%), followed by cardiac arrhythmia (in 
7.9%), need for reoperation (in 5.9%), home 
oxygen therapy (in 5.9%), pleural empyema (in 
5.9%), atelectasis (in 5.0%), acute myocardial 
infarction (in 5.0%), bronchopleural fistula (in 
4.0%), and intraoperative events (in 3.0%).
There were no statistically significant differences 
between operated and non-operated patients 
in terms of age, prevalence of comorbidities, 
prevalence of COPD, or FEV1 as a percentage of 
the predicted value. The most common reasons 
preventing surgical treatment were progression 
of cancer, treatment discontinuation or dropout, 
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than is FEV1.
(11-13) A likely explanation for this 
is loss of discriminatory power of DLCO when 
DLCO is included in an algorithm that classifies 
patients into only two categories. However, it 
should also be considered that, if our sample 
was bigger or if all patients had undergone 
DLCO measurement, the results could perhaps 
However, considering the subgroup of patients 
who underwent this test, the risk level did not 
change in 75% of the cases. This result was 
unexpected, given that DLCO has gained much 
prominence in postoperative evaluation in recent 
years, with several studies demonstrating that 
DLCO is more accurate for predicting risk of PCs 
23 did not undergo all steps of the algorithm 
239 underwent all steps of the algorithm
239 underwent spirometry
Referral for CPET (8 + 2 + 13 = 23)
262 eligible patients
10 were at an acceptable: VO2peak > 15 mL.kg
-1.min-1
8 had a FEV1ppo ≤ 40%
Referral for CPET
82 required DLCO measurement
(7 of whom had a FEV1ppo ≤ 40%
13 had a DLCOppo ≤ 40% com FEV1ppo > 40%
6 were unable to undergo DLCO measurement 
 ( 4 of whom had a FEV1ppo ≤ 40%) 
1 had a FEV1ppo and a DLCOppo ≤ 40%
2 had a FEV1ppo ≤ 40% mas DLCOppo > 40%








13 were at: 6 of whom had a VO2pico ≤ 15 mL.kg
-1.min-1
 7 of whom did not undergo CPET{
Table 2 - Morbidity and mortality rates of the 137 patients reclassified as being at an acceptable risk of 
perioperative complications after the surgical procedure, by tests performed.
Tests performed Patients Morbidity rate Mortality rate
n (%) (%) (%)
Spirometry 101 (73.7) 26.7 4.0
Spirometry + DLCO measurement 30 (21.9) 33.3 0.0
Spirometry + DLCO measurement + CPET 6 (4.4) 83.3 16.7
CPET: cardiopulmonary exercise testing.
Figure 2 - Preoperative evaluation of 239 lung resection candidates as per the American College of Chest 
Physicians algorithm guidelines. ppo: predicted postoperative; CPET: cardiopulmonary exercise testing; and 
VO2peak: peak oxygen uptake.
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from a number of studies, was proposed, but, 
unfortunately, it was not validated in a large, 
multicenter, prospective study. In comparison with 
the 2007 guidelines, these new guidelines agree 
with the European algorithm that all resection 
candidates should undergo DLCO measurement, 
as well as including the use of submaximal 
exercise tests before CPET, the development of 
new parameters for categorizing low risk, and the 
creation of a moderate-risk category. Therefore, 
when FEV1ppo and DLCOppo were above 60%, 
patients would be classified as being at low risk. If 
either of these parameters was between 30% and 
60%, patients would be referred for the shuttle 
test or the stair-climbing test. Depending on the 
results obtained, patients would undergo CPET, 
the results of which would determine whether 
the patient would be classified into the low-risk, 
moderate-risk, or high-risk category.
In an attempt to simplify the dynamic 
evaluation of cardiopulmonary reserve, much 
research has been conducted on submaximal 
exercise tests, such as the stair-climbing test, the 
six-minute walk test (6MWT), and the shuttle 
test. (18-20) Despite the satisfactory findings reported, 
some negative points have been observed. The 
lack of standardization of the stair-climbing 
test, the low level of evidence of the 6MWT, 
the variability of effort exerted during the tests, 
and, first and foremost, the fact that none of 
these tests measure more complex metabolic 
and cardiopulmonary parameters reserved for 
them the role of ascertaining if the patient really 
was at low risk of PCs. The European consensus 
guidelines and the ACCP consensus guidelines 
agree that patients who perform poorly on these 
tests should undergo CPET. It is likely that further 
studies will discuss whether or not the strategy of 
using submaximal exercise tests within the new 
be different, allowing even the creation of other 
categories, such as the moderate risk category.
Certainly, CPET is the method of choice 
for surgical risk stratification even outside the 
field of thoracic surgery; however, it is not 
widely available. (14,15) Our results showed that, 
when CPET is used after a series of tests that 
identified a patient as having limited reserve, 
which corresponded to only 9.6% of our 
population, the risk would be high in 56.6% of 
the cases. However, it is necessary to consider 
that the observed rates of PCs and mortality 
were very high. In our view, the algorithm used 
was designed in such a way that the high-risk 
category corresponded to “very high risk”, and, 
therefore, the algorithm should be improved by 
the inclusion of intermediate-risk categories.
According to the European algorithm, CPET 
should be performed when the predicted FEV1 
or DLCO value is below 80%, i.e., in the initial 
phase of the evaluation. This recommendation 
was based primarily on the studies by Bolliger et 
al.,(3,4) who had this test available at their facility 
and developed an algorithm on the basis of it. In 
contrast, the cost-effectiveness of this approach as 
compared with that of simpler evaluation strategies, 
especially in low-risk patients, is unknown. If 
we had applied the European algorithm to our 
sample, 81.7% of the population should have 
undergone CPET. A recent study conducted in 
Spain showed that, when six hospitals used that 
algorithm, of the 92 patients (53.2%) of the 
study sample who had been referred for CPET, 
only 68 underwent the test. In most cases, the 
test was not performed because of a lack of 
technical infrastructure.(16)
During the review process of our manuscript, 
the third revision of the ACCP guidelines for 
the evaluation of lung resection candidates was 
published.(17) A new algorithm, extrapolated 
Table 3 - Comparison between the groups of patients with and without perioperative complications in 
terms of age, presence of COPD, presence of other comorbidities, size of resection, and pulmonary function 
parameters.
Variable Group p*
With PCs Without PCs
Age, years 57.6 ± 11.5 61.8 ± 12.0 0.044
COPD 25.0 54.2 0.001
Other comorbidities 52.1 36.7 0.080
Lobe resection 44.8 65.3 0.003
True FEV1ppo 81.4 ± 22.3 67.9 ± 22.5 0.001
PCs: perioperative complications; and ppo: % of predicted, postoperative. *Pearson’s chi-square test and the Student’s t-test.
Morbidity, mortality, and categorization of the risk of  
perioperative complications in lung cancer patients
J Bras Pneumol. 2014;40(1):21-29
27
contributed to proper use of tests and therapeutic 
strategies, reducing cardiac morbidity rates.(22,23) 
Another contributing factor would be advances 
in the diagnosis and treatment of dyslipidemia, 
systemic arterial hypertension, diabetes mellitus, 
and coronary artery disease, reducing the systemic 
inflammatory state.
It remains controversial whether advanced 
age alone is a risk factor for PCs(24,25) or whether 
the severity and number of comorbidities that 
affect older patients are responsible for these 
complications.(9,26-28) The prevalence rate of 
comorbidities found in our study was similar to 
or lower than those reported in other studies,(8,9,29) 
as well as being similar between the groups with 
and without PCs. The opposite was true for the 
presence of COPD and the extent of resection, 
which are known to be the two most important 
risk factors related to PCs.(4,9,24)
The present study had some limitations. 
The first of these limitations was the study’s 
retrospective design. Therefore, we prioritized 
addressing complications that have the greatest 
impact, have established definitions, and had been 
used in other studies conducted at out facility, 
such as pulmonary infection, acute respiratory 
failure, and bronchopleural fistula. The second 
limitation was the modest number of patients 
studied, which precluded more complex statistical 
analysis. However, this is the first report of the 
use of the ACCP algorithm in Brazil. The third 
limitation was the possibility that critically ill 
patients were not referred to our outpatient clinic 
because they had previously been considered as 
being at very high risk. Therefore, the findings 
of the present study should not be generalized.
In conclusion, the use of the ACCP algorithm 
allowed the identification of a group of patients 
whose morbidity and mortality rates were 
considerably higher, requiring more attention 
throughout the perioperative period. The majority 
of our population was evaluated on the basis of 
spirometry alone and had acceptable morbidity 
and mortality rates. However, CPET played an 
important role in the identification of high-risk 
patients. In agreement with published studies, 
advanced age, COPD, lobe resection, and poorer 
pulmonary function were correlated with PCs.
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